1. Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats
- Author
-
Rui Zhang, Tingyu Yang, Jiani Zhou, Chunxiao Yang, Shaojun Shi, Ye Wei, Xixi Huang, and Yani Liu
- Subjects
Male ,Calcineurin Inhibitors ,Herb-Drug Interactions ,Administration, Oral ,chemical and pharmacologic phenomena ,Pharmacology ,Toxicology ,complex mixtures ,030226 pharmacology & pharmacy ,Catechin ,Tacrolimus ,Rats, Sprague-Dawley ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Pharmacokinetics ,Animals ,heterocyclic compounds ,Inhibitory effect ,Dose-Response Relationship, Drug ,food and beverages ,Biological activity ,General Medicine ,Gallate ,Rats ,Calcineurin ,chemistry ,Nuclear receptor ,Area Under Curve ,030220 oncology & carcinogenesis ,Cyclosporine ,Administration, Intravenous ,sense organs ,Immunosuppressive Agents - Abstract
Epigallocatechin-3-gallate (EGCG) is the most biologically active catechin of green tea. Tacrolimus (TAC) and cyclosporine A (CsA) are immunosuppressive agents commonly used in clinical organ transplantation. The present study investigated the effect of EGCG on the pharmacokinetics of TAC and CsA in rats and its underlying mechanisms.Either TAC or CsA was administered to rats intravenously or orally with or without concomitant EGCG. Polymerase Chain Reaction and Western Blot were used to determine the effect of EGCG on drug-metabolizing enzymes (DMEs), drug transporters (DTs) and nuclear receptors (NRs).The CThese results revealed consumption of high dose EGCG may cause a significant alteration in pharmacokinetics of TAC and distribution/elimination profiles of CsA through the regulation of DMEs, DTs and NRs.
- Published
- 2020
- Full Text
- View/download PDF